FundedIQ

Funded Startups in Daejeon

Disclosed funding in this Daejeon set is dominated by one outlier: LegoChem Biosciences’ $214M (2026-06-26), which dwarfs the rest of the disclosed rounds,…

Disclosed funding in this Daejeon set is dominated by one outlier: LegoChem Biosciences’ $214M (2026-06-26), which dwarfs the rest of the disclosed rounds, with the next-largest at $17M (Raion Robotics, 2025-09-20). Outside that top end, several rounds cluster tightly around the single-digit to teens range (e.g., $11M for MID on 2026-07-29 and two separate $7M rounds in July 2026).

Temporally, the 15 most recent entries span 2025-09-09 to 2026-07-29, with many disclosed rounds concentrated in the 2026-04 to 2026-07 window (e.g., Automata $7M on 2026-04-24; WEFLO $4M on 2026-04-07). Stage labeling is mixed: there are four “Series Unknown”/unclassified-style records (SPECTRAINTEL, LegoChem Biosciences, IVWorks, and VPIX Medical), while 11 of 15 rows have disclosed amounts and 4 of 15 are undisclosed. Sector-wise, Biotechnology appears in at least three entries (ArcGen Bioscience; LegoChem Biosciences; Lysin Bio), while Robotics shows up as a standalone category with Raion Robotics ($17M on 2025-09-20).

Most recent rounds

15 shown

Related listings

Frequently asked

Which disclosed round is the outlier, and how far ahead is it of the next-largest disclosed amount?

LegoChem Biosciences’ disclosed $214M (2026-06-26) is the only entry far above the rest; the next-largest disclosed round is $17M from Raion Robotics (2025-09-20). Everything else sits well below that top tier (e.g., $11M for MID on 2026-07-29; $7M rounds in July 2026).

How concentrated are rounds in the most recent part of the timeline (e.g., mid-2026)?

A large share of disclosed amounts falls in the 2026-04 to 2026-07 window: MID ($11M on 2026-07-29), ArcGen Bioscience ($7M on 2026-07-13), Automata ($7M on 2026-04-24), and Intergravity ($5M on 2026-04-13) are all within that period. This matches the overall span from 2025-09-09 to 2026-07-29, where mid-2026 includes multiple larger disclosed rounds.

Are there any clear sector over-representations in these 15 entries?

Biotechnology appears repeatedly across disclosed and mixed-round classifications: ArcGen Bioscience (Series A, 2026-07-13, $7M), LegoChem Biosciences (Series Unknown, 2026-06-26, $214M), and Lysin Bio (Seed, 2025-11-11, undisclosed). Robotics is represented by Raion Robotics ($17M on 2025-09-20), but other categories generally appear once in the shown slice.

What does the stage mix look like, given the prevalence of 'Series Unknown' labels?

Four of the 15 rows use a 'Series Unknown' or otherwise unclassified-style label: SPECTRAINTEL (2026-07-09, undisclosed), LegoChem Biosciences (2026-06-26, $214M), IVWorks (2026-04-02, $4M), and VPIX Medical (2025-11-02, undisclosed). By contrast, several clearly labeled rounds are concentrated among Series A (e.g., MID $11M on 2026-07-29; Raion Robotics $17M on 2025-09-20; Automata $7M on 2026-04-24).

Which entries closed earliest vs. most recently, and do the disclosed amounts follow the same pattern?

The earliest shown round date is 2025-09-09 (Nanosystem, Seed, undisclosed), while the most recent is 2026-07-29 (MID, Series A, $11M). Disclosed amounts do not strictly increase over time: the largest disclosed round is in mid-2026 (LegoChem Biosciences $214M on 2026-06-26), while another comparatively large disclosed amount appears earlier in the window with Raion Robotics’ $17M (2025-09-20).

Which rows are worth attention because the disclosed amount is near the bottom of the disclosed range or because it’s undisclosed?

At the low end of disclosed amounts, GigaEte’s $650K (Seed, 2025-09-10) is the smallest disclosed figure. Separately, four entries have undisclosed amounts—SPECTRAINTEL (2026-07-09), Lysin Bio (2025-11-11), VPIX Medical (2025-11-02), and Nanosystem (2025-09-09)—so those are the main candidates where funding size cannot be compared directly despite being part of the most recent city set.

Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.